Toward Personalized Treatment Approaches in Soft Tissue Sarcomas.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 1, p. 31
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2024 AND VI 38 AND IP 1
Results: 11
1
2
Defining a Space for NRG1 Fusion--Positive Tumors in Lung and GI Cancers.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 1, p. 28
- By:
- Publication type:
- Article
3
Radical Hysterectomies Show Sexual Toxicity in Early-Stage Cervical Cancer.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 1, p. 27
- Publication type:
- Article
4
Dostarlimab Combo Significantly Improves PFS in Advanced Endometrial Cancer.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 1, p. 27
- Publication type:
- Article
5
Induction Chemotherapy/CRT Improves Efficacy in Advanced Cervical Cancer.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 1, p. 26
- Publication type:
- Article
6
Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in Italy.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 1, p. 15
- By:
- Publication type:
- Article
7
Building Efficiency and Scaling With a Remote Genetic Counseling Program.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 1, p. 20
- By:
- Publication type:
- Article
8
Trastuzumab Deruxtecan Showcases Clinical Efficacy in HER2+ Gynecological Cancers.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 1, p. 26
- Publication type:
- Article
9
Tiragolumab Plus Atezolizumab Will Not Be Pursued in Further Cervical Cancer Management.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 1, p. 12
- By:
- Publication type:
- Article
10
PUBLISHER'S NOTE.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 1, p. 10
- Publication type:
- Article
11
Co--Editor-in-Chief Introduction: Priorities and New Directions.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 1, p. 11
- By:
- Publication type:
- Article